# A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy Participants

> **NCT03007693** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 71 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-61393215
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03007693
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007693, "A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03007693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*